We have compiled a list of manufacturers, distributors, product information, reference prices, and rankings for medicine.
ipros is IPROS GMS ・ IPROS One of the largest technical database sites in Japan that collects information on.

medicine Product List and Ranking from 35 Manufacturers, Suppliers and Companies

Last Updated： Aggregation Period:Dec 24, 2025～Jan 20, 2026
This ranking is based on the number of page views on our site.

medicine Manufacturer, Suppliers and Company Rankings

Last Updated： Aggregation Period:Dec 24, 2025～Jan 20, 2026
This ranking is based on the number of page views on our site.

  1. マーケットリサーチセンター Tokyo//Service Industry
  2. null/null
  3. Tohoku Techno Arch Co., Ltd. Miyagi//Educational and Research Institutions
  4. 4 バイオマテックジャパン Hokkaido//Pharmaceuticals and Biotechnology
  5. 5 KANTO CHEMICAL CO., INC. Biochemical Dept Tokyo//Chemical
Go to Company Ranking

medicine Product ranking

Last Updated： Aggregation Period:Dec 24, 2025～Jan 20, 2026
This ranking is based on the number of page views on our site.

  1. Pharmaceutical CDMO services 大塚化学
  2. Ouchi Shinko Chemical Industry Co., Ltd. 須賀川市 経済環境部商工課
  3. Contract development and manufacturing (CDMO) business for mid-sized molecules (oligonucleotides and peptides) active pharmaceutical ingredients.
  4. Natural Proteoglycan, the Herbal Medicine of the Sea バイオマテックジャパン
  5. 4 For various titrations! The titration "indicator" specified in JIS K8001. KANTO CHEMICAL CO., INC. Biochemical Dept

medicine Product List

421～435 item / All 599 items

Displayed results
[Research Material] Global Market for Leishmaniasis Treatment

[Research Material] Global Market for Leishmaniasis Treatment

Global Market for Leishmaniasis Treatment: Meglumine Antimoniate, Pentamidine, Hydroxyamidine Stilbene, Amphotericin B, etc.

This research report (Global Leishmaniasis Treatment Market) investigates and analyzes the current state and outlook for the global market for leishmaniasis treatment over the next five years. It includes information on the overview of the global leishmaniasis treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the leishmaniasis treatment market focus on meglumine antimoniate, pentamidine, hydroxymethyl-stilbene, and amphotericin B, while the segments by application target visceral leishmaniasis and cutaneous leishmaniasis. The regional segments calculate the market size for leishmaniasis treatment by dividing it into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in leishmaniasis treatment, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Nosebleed Treatment Drugs

[Research Material] Global Market for Nosebleed Treatment Drugs

Global Market for Nosebleed Treatments: Vasoconstrictors, Anesthetics, Antibiotic Ointments, Cauterizing Agents, Septal Deviation, Intranasal Inflammation, Others

This research report (Global Epistaxis Therapeutics Market) investigates and analyzes the current state and outlook for the global market for epistaxis therapeutics over the next five years. It includes information on the global epistaxis therapeutics market overview, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the epistaxis therapeutics market include vasoconstrictors, anesthetics, antibiotic ointments, and cauterizing agents, while the segments by application focus on septal deviation, nasal inflammation, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for epistaxis therapeutics. It also includes the market share of major companies in epistaxis therapeutics, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Rare Disease Therapeutics

[Research Material] Global Market for Rare Disease Therapeutics

World Market for Rare Disease Treatments: Above 1‰, 0.65‰ to 1‰, Below 0.1‰, Hospital Pharmacies, Specialty Pharmacies, Retail Pharmacies, Others

This research report (Global Rare Disease Drug Market) investigates and analyzes the current status and outlook for the global market for rare disease treatments over the next five years. It includes information on the overview of the global rare disease treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include those with a prevalence of 1‰ or more, 0.65‰ to 1‰, and 0.1‰ or less, while the segments by application focus on hospital pharmacies, specialty pharmacies, retail pharmacies, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for rare disease treatments. The report also includes the market share of major companies in the rare disease treatment sector, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Ibandronic Acid Sodium

[Research Material] Global Market for Ibandronic Acid Sodium

World Market for Sodium Ibandronate: ≥98%, <98%, Osteoporosis, Bone Pain, Hypercalcemia, Others

This research report (Global Ibandronate Sodium Market) investigates and analyzes the current state and outlook for the global ibandronate sodium market over the next five years. It includes information on the overview of the global ibandronate sodium market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type focus on ≥98% and <98%, while the segments by application cover osteoporosis, bone pain, hypercalcemia, and others. The regional segments calculate the market size of ibandronate sodium by dividing it into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in ibandronate sodium, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Epigenetics Pharmaceuticals and Diagnostic Technologies

[Research Material] Global Market for Epigenetics Pharmaceuticals and Diagnostic Technologies

Global Market for Epigenetics Pharmaceuticals and Diagnostic Technologies: Epigenetics Drugs, Epigenetics Diagnostic Technologies, Hospitals, Research Institutions, Others

This research report (Global Epigenetics Drugs & Diagnostic Technologies Market) investigates and analyzes the current status and future outlook of the global market for epigenetics drugs and diagnostic technologies over the next five years. It includes information on the overview of the global epigenetics drugs and diagnostic technologies market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include epigenetics drugs and epigenetics diagnostic technologies, while the segments by application target hospitals, research institutions, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for epigenetics drugs and diagnostic technologies. It also includes the market share of major companies in epigenetics drugs and diagnostic technologies, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Dermatitis Treatment Drugs

[Research Material] Global Market for Dermatitis Treatment Drugs

World Market for Dermatitis Treatments: Calcineurin Inhibitors, Corticosteroids, Biologics, Others, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

This research report (Global Dermatitis Drugs Market) investigates and analyzes the current state and outlook for the global market for dermatitis treatment drugs over the next five years. It includes information on the overview of the global dermatitis treatment drugs market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the dermatitis treatment drugs market include calcineurin inhibitors, corticosteroids, biologics, and others, while the segments by application include hospital pharmacies, retail pharmacies, and online pharmacies. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for dermatitis treatment drugs. It also includes the market share of major companies in dermatitis treatment drugs, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Treatment of Idiopathic Intracranial Hypertension

[Research Material] Global Market for Treatment of Idiopathic Intracranial Hypertension

Global Market for Treatment of Idiopathic Intracranial Hypertension: Acetazolamide, Furosemide, Topiramate, Octreotide, Hospital Pharmacies, Retail Pharmacies, Others

This research report (Global Idiopathic Intracranial Hypertension Therap) investigates and analyzes the current status and outlook for the global market of treatments for idiopathic intracranial hypertension over the next five years. It includes information on the overview of the global idiopathic intracranial hypertension treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include acetazolamide, furosemide, topiramate, and octreotide, while the segments by application focus on hospital pharmacies, retail pharmacies, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for idiopathic intracranial hypertension treatments. The report also includes the market share of major companies in the idiopathic intracranial hypertension treatment sector, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Angina Treatment Drugs

[Research Material] Global Market for Angina Treatment Drugs

Global Market for Angina Treatment Drugs: Beta Blockers, Calcium Channel Blockers, Anticoagulants, Antiplatelet Agents, Others, Hospitals, Clinics, ASC

This research report (Global Angina Pectoris Drugs Market) investigates and analyzes the current status and outlook for the global market of angina treatment drugs over the next five years. It includes information on the overview of the global angina treatment drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include beta-blockers, calcium channel blockers, anticoagulants, antiplatelet agents, and others, while the segments by application focus on hospitals, clinics, and ASCs. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for angina treatment drugs. It also includes the market share of major companies in the angina treatment drug sector, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Document] Global Market for Fluticasone Propionate & Salmeterol

[Research Document] Global Market for Fluticasone Propionate & Salmeterol

World Market for Fluticasone Propionate & Salmeterol: Inhalation Powder, Inhalation Aerosol, Asthma, COPD

This research report (Global Fluticasone Propionate and Salmeterol Market) investigates and analyzes the current status and outlook for the global market of fluticasone propionate and salmeterol over the next five years. It includes information on the overview of the global fluticasone propionate and salmeterol market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type for fluticasone propionate and salmeterol focus on inhalation powder and inhalation aerosol, while the segments by application target asthma and COPD. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for fluticasone propionate and salmeterol. It also includes the market share of major companies in fluticasone propionate and salmeterol, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Neutropenia Treatment Drugs

[Research Material] Global Market for Neutropenia Treatment Drugs

World Market for Treatment of Neutropenia: Capsules, Injections, Hospitals, Clinics

This research report (Global Neutropenia Drugs Market) investigates and analyzes the current state and future outlook of the global market for neutropenia treatment drugs over the next five years. It includes information on the overview of the global neutropenia treatment drugs market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include capsules and injections, while the segments by application focus on hospitals and clinics. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, calculating the market size for neutropenia treatment drugs accordingly. It also includes the market share of major companies in the neutropenia treatment drugs sector, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Palonosetron Hydrochloride

[Research Material] Global Market for Palonosetron Hydrochloride

World Market for Palonosetron Hydrochloride: Purity ≥ 98%, Purity ≥ 99%, Palonosetron Hydrochloride Injection, Palonosetron Hydrochloride Oral Capsules

This research report (Global Palonosetron Hydrochloride Market) investigates and analyzes the current status and outlook for the global market of palonosetron hydrochloride over the next five years. It includes information on the overview of the global palonosetron hydrochloride market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments of the palonosetron hydrochloride market by type focus on purity levels of ≥98% and ≥99%, while the segments by application cover palonosetron hydrochloride injection solutions and palonosetron hydrochloride oral capsules. The regional segments calculate the market size of palonosetron hydrochloride by dividing it into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in palonosetron hydrochloride, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for Wilm's Tumor Treatment

[Research Material] The Global Market for Wilm's Tumor Treatment

Global Market for Wilms Tumor Treatment: Cabozantinib, SEL-12034, Lacutamab, Others, Hospitals, Clinics, Others

This research report (Global Wilms' Tumor Treatment Market) investigates and analyzes the current state and outlook for the global market for Wilms' tumor treatment over the next five years. It includes information on the overview of the global Wilms' tumor treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the Wilms' tumor treatment market include cabozantinib, SEL-12034, lacutamab, and others, while the segments by application include hospitals, clinics, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for Wilms' tumor treatment. It also includes the market share of major companies in Wilms' tumor treatment, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Treatment of Tropical Spastic Paraplegia

[Research Material] Global Market for Treatment of Tropical Spastic Paraplegia

Global Market for Tropical Spastic Paraplegia Treatment: 17-Alpha-Ethynyltestosterone, Mogamulizumab, Others, Hospitals, Clinics, Surgeons ...

This research report (Global Tropical Spastic Paraparesis Treatment Mark) investigates and analyzes the current state and outlook for the global market for tropical spastic paraparesis treatment over the next five years. It includes information on the overview of the global tropical spastic paraparesis treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include 17-alpha-ethynyltestosterone, mogamulizumab, and others, while the segments by application focus on hospitals, clinics, surgical hospitals, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for tropical spastic paraparesis treatment. It also includes the market share of major companies in tropical spastic paraparesis treatment, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for CARASIL Treatment

[Research Material] The Global Market for CARASIL Treatment

Global Market for CARASIL Treatment: Vesicular Monoamine Transporter 2 Inhibitors, Selective Serotonin Reuptake Inhibitors (SSRIs), Cholinergic/...

This research report (Global Carasil Treatment Market) investigates and analyzes the current status and outlook for the global CARASIL treatment market over the next five years. It includes information on the overview of the global CARASIL treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the CARASIL treatment market include vesicular monoamine transporter 2 inhibitors, selective serotonin reuptake inhibitors (SSRIs), cholinergic/cholinesterase (Che) inhibitors, atypical antipsychotics, combination drugs (donepezil and memantine), MAO inhibitors, and glutamate inhibitors. The segments by application target hospitals, clinics, drugstores, and online pharmacies. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for CARASIL treatment. The report also includes the market share of major companies in CARASIL treatment, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for Hospital-Acquired Infection Treatment

[Research Material] The Global Market for Hospital-Acquired Infection Treatment

World Market for Hospital-Acquired Infection Treatment: Antibiotics, Antivirals, Antifungals, Hospital-Acquired Pneumonia, Surgical Site Infections, Urinary Tract Infections, Gastrointestinal Diseases, Bacteremia, Others

This research report (Global Hospital Infection Therapeutics Market) investigates and analyzes the current status and outlook for the global market for hospital infection treatment over the next five years. It includes information on the overview of the global hospital infection treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the hospital infection treatment market focus on antibiotics, antiviral drugs, and antifungal drugs, while the segments by application cover hospital-acquired pneumonia, surgical site infections, urinary tract infections, gastrointestinal diseases, bacteremia, and others. The regional segments calculate the market size for hospital infection treatment categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in hospital infection treatment, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

Search Keywords Related to medicine

COPYRIGHT © 2001-2026 IPROS CORPORATION ALL RIGHTS RESERVED.